Company Filing History:
Years Active: 2014
Title: The Innovations of Wenju Wu
Introduction
Wenju Wu is a notable inventor based in Hillsborough, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for various medical applications. His work is characterized by a focus on innovative solutions to complex health issues.
Latest Patents
Wenju Wu holds 1 patent for his invention titled "Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide." This invention is directed towards a novel crystalline form of the compound, which is utilized in pharmaceutical compositions. The applications of this crystalline form include the treatment of anxiety and related disorders, bipolar depression and mania, epilepsy, glucose-related disorders, lipid-related disorders, migraine, obesity, pain, substance abuse, and neuroprotection. Additionally, the patent outlines a process for the preparation of this novel crystalline form.
Career Highlights
Wenju Wu is currently associated with Janssen Pharmaceutica NV, where he continues to contribute to pharmaceutical research and development. His work at Janssen has allowed him to collaborate with other experts in the field, enhancing the impact of his innovations.
Collaborations
One of his notable collaborators is Steven Mehrman. Together, they have worked on various projects that aim to advance the understanding and treatment of complex medical conditions.
Conclusion
Wenju Wu's innovative contributions to the pharmaceutical industry demonstrate his commitment to improving health outcomes through research and development. His patent for a novel crystalline form of a pharmaceutical compound highlights the potential for new treatments in various medical fields.